Metaboost Rx review

What it is

Metaboost Rx LLC lists a mailing address on North Classen Boulevard in Oklahoma City, Oklahoma, and its terms apply Delaware law. It calls itself a physician-directed telehealth practice on its About page, but its disclaimer and terms describe a technology platform that connects patients with independent, board-certified providers and state-licensed compounding pharmacies, and say it doesn't practice medicine, write prescriptions or dispense drugs. The terms add that the subscription price bundles the pharmacy's fee for the drug, the medical group's fee for the provider and the platform's own fee, but the site names none of them. Beyond weight loss, it sells compounded sermorelin, tesamorelin, PT-141 and NAD⁺. It's self-pay only. Support is by email or phone, weekdays from 9 a.m. to 5 p.m., and the contact form promises a reply within 24 hours.

How it works

You start with an online assessment the site says takes five to ten minutes, covering your history, goals and baseline. A licensed provider reviews it and, if treatment is appropriate, writes a prescription that a partner compounding pharmacy prepares and ships in discreet, cold-chain packaging. For semaglutide, the site lists adults with a BMI of 27 or more, or 25 or more with a weight-related condition, as the usual fit, and conditions such as high blood pressure or type 2 diabetes don't automatically rule you out. If you're switching from another provider, you may be able to continue at the same or an equivalent dose. After that, care runs through structured check-ins and direct messaging with your provider, with dose changes as you go. The peptide programs follow the same route; sermorelin is a nightly injection timed to bedtime, with the dose and cadence set by your provider.

Pricing transparency

The homepage advertises compounded semaglutide "from $129/mo" beside a struck-through $199 and tirzepatide "from $149/mo" beside $249, covering the online provider visit, prescription, home delivery and ongoing check-ins, and notes that plans are confirmed after provider review. The site doesn't say whether the lower figure is a first-month price, a longer-plan rate or a starting dose. Its peptides page lists the lower-dose GLP-1 from $199 a month, the oral GLP-1 from $229, sermorelin from $249, tesamorelin from $299, PT-141 from $249 and NAD⁺ from $199. The program pages promise flat pricing with no consultation charges or dose-change surcharges, and the FAQ says no long-term commitment is required. Under its terms, you're charged when you order and every 30 days after until you cancel, with a reminder five to seven days before each charge. The program pages say memberships need 30 days' notice to cancel, while the terms let you turn off auto-refill up to 48 hours before the next charge. A prescription order can be canceled only within 24 hours, and refunds are limited to an unshipped order, a wrong or damaged product, or a provider who declines to prescribe; you pay nothing if you aren't approved.

Branded vs compounded

Providers can prescribe compounded semaglutide and compounded tirzepatide as weekly injections, a lower-dose GLP-1 protocol and a daily oral GLP-1, prepared by partner compounding pharmacies in the U.S. The site states that compounded medications are not FDA-approved, that their safety, effectiveness and quality haven't been verified by the FDA, and that compounded semaglutide and tirzepatide aren't the same as the brand-name drugs. The weight-loss trajectory it shows is drawn from trials of the brand-name drugs, which it says. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered. Its peptide menu includes sermorelin, tesamorelin and PT-141, plus NAD⁺. Metaboost Rx doesn't display a LegitScript seal. A search of the FDA warning-letter database under its name returned no letters.

Pros and watch-outs

The evidence behind what Metaboost Rx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• Sermorelin benefits: does it work? What the trials show

  A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.

• Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidence

  A real, approved GHRH analog — for HIV-associated lipodystrophy specifically. What the pivotal trials showed, and why the longevity use is an extrapolation.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Metaboost Rx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• WellMedRx

  Compounded GLP-1s by injection or tablet, with a named clinician network and pharmacy

  See WellMedRx →
• Enhance MD

  Lab-guided treatment under ongoing physician oversight

  See Enhance MD →
• LVNG RX

  Cash buyers who want a compounded GLP-1, a lower-dose option or growth-hormone peptides from one platform

  See LVNG RX →

More GLP-1 telehealth reviews: Lovely Meds · LumiMeds · Lumen Meds · LifeVine Wellness · Liv Body · Luci